Abstract
In order to investigate the molecular basis of phenylketonuria (PKU) in Spain, we analyzed the restriction fragment length polymorphism (RFLP) haplotypes and common mutations in the phenylalanine hydroxylase (PAH) gene in 32 unrelated Spanish PKU families. The distribution of RFLP haplotypes differs from that of northern Europe. Mutant haplotypes 2 and 3 were completely absent in our sample. Approximately 65% of the mutant alleles are confined to three RFLP haplotypes, namely haplotypes 1, 6 and 9, also frequently found in other Mediterranean populations. We screened for previously described PKU mutations using the polymerase chain reaction and allele-specific oligonucleotides, and found IVS10,165T, E280K and P281L as the major mutations, representing 41% of the PKU alleles. Other mutations found were Y414C, and a new one, P244L. Mutations R408W and IVS12, prevalent in northern Europe, as well as others present in southern European populations (R252W, R261Q, L249F) were not detected in our sample. Our results reveal the genetic heterogeneity present in the Spanish PKU population, which shows similarities to others of Mediterranean origin.
Similar content being viewed by others
References
Abadie V, Lyonnet S, Maurin N, Berthelon M, Caillaud C, Giraud F, Matei JF, Rey J, Rey F, Munnich A (1989) CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics 5: 936–939
Caillaud C, Vilarinho L, Vilarinho A, Rey F, Berthelon M, Santos R, Lyonnet S, Briard ML, Osorio RV, Rey J, Munnich A (1992) Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal. Hum Genet 89:69–72
Dasovich M, Konecki D, Lichter-Konecki U, Eisensmith RC, Güttler F, Naughton E, Mullins C, Giovannini M, Riva E, Woo SLC (1991) Molecular characterization of a PKU allele prevalent in Southern Europe and Ireland. Somatic Cell Mol Genet 17: 303–309
Desviat LR, Perez B, Ugarte M (1992) A new PKU mutation associated with haplotype 12. Hum Mol Genet 9:765–766
DiLella AG, Marvit J, Lidsky AS, Güttler F, Woo SLC (1986) Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 322:799–803
DiLella AG, Marvit J, Brayton K, Woo SLC (1987) An amino acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature 327:333–336
DiLella AG, Huang WM, Woo SLC (1988) Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet 1:497–499
Dworniczak B, Aulehla-Scholz C, Kalaydjieva L, Bartholomé K, Grudda K, Horst J (1991a) Aberrant splicing of phenylalanine hydroxylase mRNA: the major cause for phenylketonuria in parts of Southern Europe. Genomics 11:242–246
Dworniczak B, Grudda K, Stümper J, Bartholomé K, Aulehla-Scholz C, Horst J (1991b) Phenylalanine hydroxylase gene: novel missense mutation in exon 7 causing severe phenylketonuria. Genomics 9:193–199
Dworniczak B, Wedemeyer N, Eigel A, Horst J (1991c) PCR detection of the BglII RFLP at the human phenylalanine hydroxylase (PAH) locus. Nucleic Acids Res 19:1958
Eisensmith RC, Woo SLC (1992) Updated listing of haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 51:1445–1448
Eisensmith RC, Okano Y, Dasovich M, Wang T, Güttler F, Lou H, Guldberg P, Lichter-Konecki U, Konecki DS, Svensson E, Hagenfeldt L, Rey F, Munnich A, Lyonnet S, Cockburn F, Connor JM, Pembrey ME, Smith I, Gitzelmann R, Steinmann B, Apold J, Eiken HG, Giovannini M, Riva E, Longhi R, Romano C, Cerone R, Naughten ER, Mullins C, Cahalane S, Özalp I, Fekete G, Schuler D, Berencsi GY, Nász I, Brdicka R, Kamaryt J, Pijackova A, Cabalska B, Boszkowa K, Schwartz E, Kalinin VN, Jin L, Chakraborty R, Woo SLC (1992) Multiple origins for phenylketonuria in Europe. Am J Hum Genet 51: 1355–1365
Goltsov AA, Eisensmith RC, Woo SLC (1991) Detection of the XmnI RFLP at the human PAH locus by PCR. Nucleic Acids Res 20:927
Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SLC (1992) Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 51:627–636
Güttler F (1980) Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Paediatr Scand [Suppl] 280:1–80
John SWM, Weitzner G, Rozen R, Scriver CR (1991) A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 19:408
John SWM, Scriver CR, Laframboise R, Rozen R (1992) In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus. Hum Mutat 1:147–153
Kwok SCM, Ledley FD, DiLella AG, Robson KJH, Woo SLC (1985) Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556–561
Lidsky AS, Ledley FD, DiLella AG, Kwok SCM, Daiger SP, Robson KJH, Woo SLC (1985) Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet 37:619–634
Lyonnet S, Caillaud C, Rey F, Berthelon M, Frézal J, Rey J, Munnich A (1989) Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet 44:511–517
Lyonnet S, Melle D, Braekeleer M de, Laframboise R, Rey F, John SWM, Berthelon M, Berthelot J, Journel H, Le Marec B, Parent P, Parscau L de, Saudubray JM, Rozen R, Rey J, Munnich A, Scriver CR (1992) Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France. Am J Hum Genet 51:191–196
Okano Y, Wang T, Eisensmith RC, Longhi R, Riva E, Giovannini M, Cerone R, Romano C, Woo SLC (1991a) Phenylketonuria missense mutations in the Mediterranean. Genomics 9:96–103
Okano Y, Eisensmith RC, Dasovich M, Wang T, Güttler F, Woo SLC (1991b) A prevalent missense mutation in Northern Europe associated with hyperphenylalaninemia. Eur J Pediatr 150:347–352
Okano Y, Eisensmith RC, Güttler F, Lichter-Konecki U, Konecki S, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC (1991c) Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232–1238
Old J (1986) Fetal DNA analysis. In: Davies K (eds) Human geetic diseases: a practical approach. IRL Press, New York, pp 1–16
Pérez B, Desviat LR, Díe M, Ugarte M (1992) Mutation analysis of phenylketonuria in Spain: prevalence of two Mediterranean mutations. Hum Genet 89:341–342
Reichardt J, Woo SLC (1991) Molecular basis of galactosemia: mutations and polymorphisms in the gene encoding human galactose-1-phosphate urydiltransferase. Proc Natl Acad Sci USA 88:2633–2637
Rey F, Berthelon M, Caillaud C, Lyonnet S, Abadie V, Blandin-Savoja F, Feingold J, Saudubray JM, Frézal J, Munnich A, Rey J (1988) Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France. Am J Hum Genet 43:914–921
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463
Svensson E, Andersson B, Hagenfeldl L (1990) Two mutations within the coding sequence of the phenylalanine hydroxylase gene. Hum Genet 85:300–304
Trefz FK, Schmidt H, Bartholomé K, Mahle M, Matthis P, Pecht G (1985) Differential diagnosis and significance of various hyperphenylalaninemias. In: Bickel H, Wachtel U (eds) Inherited diseases of amino acid metabolism. Thieme, Stuttgart, New York, pp 86–100
Ugarte M (1982) Neonatal screening programme for aminoacid disorders and congenital hypothyroidism in Spain. In: Naruse H, Irie M (eds) Neonatal screening. International symposium on neonatal screening for inborn errors of metabolism. Excerpta Medica, Amsterdam, pp 491–492
Wedemeyer N, Dworniczak B, Horst J (1991) PCR detection of the MspI(Aa) RFLP at the human phenylalanine hydroxylase (PAH) locus. Nucleic Acids Res 19:1959
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Desviat, L.R., Pérez, B. & Ugarte, M. Phenylketonuria in Spain: RFLP haplotypes and linked mutations. Hum Genet 92, 254–258 (1993). https://doi.org/10.1007/BF00244468
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00244468